Clinicians have obligations of justice when treating patients, which can lead to difficult decisions on how to ethically allocate limited resources to patients as a whole, said Jacqueline Glover, PhD, professor in the Department of Pediatrics and the Center for Bioethics and Humanities at the University of Colorado Denver.
Clinicians have obligations of justice when treating patients, which can lead to difficult decisions on how to ethically allocate limited resources to patients as a whole, said Jacqueline Glover, PhD, professor in the Department of Pediatrics and the Center for Bioethics and Humanities at the University of Colorado Denver.
Transcript (slightly modified)
When considering an ethical framework for healthcare, what is the physician role regarding costs?
We think about clinicians as professionals, as having role-specific obligations, and it’s never part of a doctor’s, for example, role to consider costs. We want our clinicians to be gatekeepers, but only gatekeepers that swing the door maximally open. They should only consider one patient at a time, and never cost.
I think that’s not true. I think healthcare professionals have obligations of justice, just like you and I have obligations of justice, uncontrolled spending by some puts at risk the availability of some other things, or the very same thing, to others. Clinicians have obligations of justice because we all do.
We also think that the only benefits are on the side of receiving the drug, and that’s not necessarily true. High-cost drugs, not only with the side effects of any drug, but high-cost drugs may not have good outcomes because they’re so expensive. Patients who can’t afford them may start the treatment later, may not take the drug, may not be as compliant, and they may stop taking the drug because of cost.
So, healthcare professionals have obligations to consider patients’ benefit, but also obligations of justice to consider their patients altogether. Human needs are limitless, but our ability to respond to those needs are limited. Our resources are limited, and so cost is an ethical concern, because we have to figure out how best to use our limited resources on behalf of patients and on behalf of all the patients together, what we call the common good.
If we thought of time instead of cost, we don’t expect our doctors to spend all of their time with us. We realize that physicians, nurses, pharmacists have obligations to other patients, so we recognize that with time allocation. It’s the same thing for allocation of cost.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More